Author/Authors :
Agasthi, Pradyumna Department of Cardiovascular Diseases - Mayo Clinic, Arizona, USA , Narayanasamy, Hemalatha Department of Cardiovascular Diseases - Mayo Clinic, Arizona, USA , Sorajja, Dan Department of Cardiovascular Diseases - Mayo Clinic, Arizona, USA , Slack, James Department of Cardio-Oncology - Mayo Clinic, Arizona, USA , Mookadam, Farouk Department of Cardio-Oncology - Mayo Clinic, Arizona, USA
Abstract :
Decitabine is a pyrimidine analogue of nucleoside cytidine, used for the treatment of myelodysplastic syndromes, chronic
myelogenous leukemia, and acute myelogenous leukemia. We present a case of cardiomyopathy associated with decitabine
used for secondary acute myelogenous leukemia. The patient presented with new heart failure symptoms and an ejection
fraction decline.
